Description
NATIONAL CMOP - SUMATRIPTAN 6MG/0.5ML INJ SYRINGE 0.5ML 2CT, S0174 IMF #9143
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-08-08+$690,540= $690,540
- Mod P000012025-08-20+$0= $690,540
- Mod P000022025-11-04-$301= $690,239
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-08-08 | +$690,540 | $690,540 | NATIONAL CMOP - SUMATRIPTAN 6MG/0.5ML INJ SYRINGE 0.5ML 2CT, S0174 IMF #9143 |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2025-08-20 | +$0 | $690,540 | NATIONAL CMOP - SUMATRIPTAN 6MG/0.5ML INJ SYRINGE 0.5ML 2CT, S0174 IMF #9143 |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-11-04 | −$301 | $690,239 | NATIONAL CMOP - SUMATRIPTAN 6MG/0.5ML INJ SYRINGE 0.5ML 2CT, S0174 IMF #9143 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GQLDJJ8AQNN5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726D0041 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0042 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0022 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0014 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0023 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0018 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026P0118 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $30,935 | FY2026 |
| 36C77026P0129 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $76,656 | FY2026 |
| 36C77026P0127 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $58,395 | FY2026 |
| 36C77026P0086 | SAGENT PHARMACEUTICALS, INC | NATIONAL CMOP OFFICE (36C770) | $275,580 | FY2026 |
| 36C77026P0095 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $83,520 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77025P0181_3600_-NONE-_-NONE- · retrieved 2026-09-26.